智通财经APP讯,京玖康疗(00648)发布截至2024年12月31日止年度业绩,收益5463.9万港元,同比增长6.43%;年内溢利及全面收益总额3.26亿港元,同比增长2508.24%;每股盈利1港元。
据悉,公司拥有人应占综合溢利3.26亿港元主要来自于年内以安排计划方式实施债务重组产生的一次性收益。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.